CFTR and cystic fibrosis: Although HEMT has and will continue to improve outcomes substantially for individuals with CF, many with advanced lung disease could benefit from LTx, and respondents in our study valued feeling informed and prepared for LTx decision-making regardless of lung function or CFTR modulator status.